Company TransMedics Group, Inc.

Equities

TMDX

US89377M1099

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
86.51 USD +2.79% Intraday chart for TransMedics Group, Inc. -5.78% +9.60%

Business Summary

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Number of employees: 584

Sales per Business

USD in Million2022Weight2023Weight Delta
Liver Organ Care System
64.1 %
46 49.5 % 152 64.1 % +228.20%
Heart Organ Care System
30.9 %
38 41.0 % 73 30.9 % +90.58%
Lung Organ Care System
5.0 %
9 9.5 % 12 5.0 % +33.60%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
93.5 %
84 89.9 % 221 93.5 % +163.39%
All Other Countries
6.5 %
9 10.1 % 15 6.5 % +63.34%

Managers

Managers TitleAgeSince
Founder 55 98-07-31
Director of Finance/CFO 56 15-02-28
Chief Tech/Sci/R&D Officer - 06-02-28
Chief Tech/Sci/R&D Officer 60 19-07-31
Chief Tech/Sci/R&D Officer 60 19-02-28
Chief Operating Officer 59 06-01-31
Investor Relations Contact - -
General Counsel - 23-07-25
Corporate Officer/Principal - 23-02-01
Human Resources Officer - 19-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 79 10-12-31
Director/Board Member 67 02-12-31
Director/Board Member 68 20-12-31
Director/Board Member 73 16-07-31
Director/Board Member 76 16-01-31
Founder 55 98-07-31
Director/Board Member 64 21-03-21
Director/Board Member 60 18-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,851,311 31,661,550 ( 96.38 %) 0 96.38 %

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
14.76 %
4,828,744 14.76 % 357 M $
BlackRock Advisors LLC
7.400 %
2,421,000 7.400 % 179 M $
Vanguard Fiduciary Trust Co.
5.701 %
1,865,115 5.701 % 138 M $
Macquarie Investment Management Business Trust
4.664 %
1,525,819 4.664 % 113 M $
Fred Alger Management LLC (13f Subfiler)
4.105 %
1,342,915 4.105 % 99 M $
Invesco Advisers, Inc.
3.487 %
1,140,851 3.487 % 84 M $
Driehaus Capital Management LLC
3.333 %
1,090,507 3.333 % 81 M $
Lord, Abbett & Co. LLC
3.135 %
1,025,564 3.135 % 76 M $
ArrowMark Colorado Holdings LLC
3.120 %
1,020,838 3.120 % 75 M $
Eventide Asset Management LLC
3.039 %
994,240 3.039 % 74 M $

Company contact information

TransMedics Group, Inc.

200 Minuteman Road Suite 302

01810, Andover

+978 552 0900

http://www.transmedics.com
address TransMedics Group, Inc.(TMDX)
  1. Stock Market
  2. Equities
  3. TMDX Stock
  4. Company TransMedics Group, Inc.